Bicara Therapeutics Inc. Common Stock (BCAX) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of Bicara Therapeutics Inc. Common Stock and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BCAX vs TDOC

growth of $100 · dividends reinvested · last 2y
BCAX -26.1% (-14.1%/yr)TDOC -24.0% (-12.8%/yr)TDOC compounded faster over this window
50100150Start $10020252026$74$76
BCAX TDOC

BCAX vs TDOC: by the numbers

  • •BCAX is the larger company ($1.14B vs $1.05B market cap).
  • •Both run net losses; BCAX's is the smaller (0.00% vs -7.13% net margin).

Metrics side by side

Valuation

MetricBCAXTDOC
P/S ratioN/A0.42
P/B ratio2.420.80
EV / EBITDAN/A12.93
FCF yieldN/A21.36%

Profitability

MetricBCAXTDOC
Gross margin0.00%73.53%
Operating margin0.00%-6.98%
Net margin0.00%-7.13%
ROE-39.54%-13.54%
ROIC-42.98%-7.32%

Growth (annualized)

MetricBCAXTDOC
Revenue CAGR (5Y)N/A8.85%
Total return CAGR (5Y)N/A-45.85%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.